Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
This week on MIA Radio we turn our attention to psychiatric drug withdrawal and in particular the work of the International Institute for Psychiatric Drug Withdrawal.
The Institute recently held a network meeting in Gothenburg, Sweden, where 40 leading experts from around the world came together to discuss the issues of dependence, withdrawal and iatrogenic harm relating to psychiatric drugs. The meeting participants included both professionals and those with lived experience.
We chat with IIPDW founder Carina Håkansson and IIPDW Board Member Professor John Read.
Following the meeting, the IIPDW released the following Press Release.
INTERNATIONAL EXPERTS CALL FOR SERVICES TO SUPPORT MILLIONS TRYING TO COME OFF PSYCHIATRIC DRUGSMillions of people around the world are currently trying to come off psychiatric drugs but finding it extremely difficult because of withdrawal effects which are often severe and persistent, and because there is so little support available to come off the drugs slowly and safely.
The 40 international experts attending this weekend’s meeting (end of September 2019) of the International Institute for Psychiatric Drug Withdrawal (www.iipdw.org) voted to endorse the recommendations of the recent Public Health England [PHE] review of ‘Dependence and withdrawal associated with prescribed medicines’ and pledged to try to implement them in the 15 countries they are from, and beyond. These include:
Enhancing clinical guidance and the likelihood it will be followed. Improving information for patients and carers on prescribed medicines, and increasing informed choice and shared decision-making between clinicians and patients. Improving the support available from the healthcare system for patients experiencing dependence on, or withdrawal from, prescribed medicines. Further research on the prevention and treatment of dependence on, and withdrawal from, prescribed medicines.Participants agreed that besides antidepressants and benzodiazepines other psychoactive drugs, e.g. antipsychotics, should be included. They also agreed with PHE that ‘the goal is to make sure that our healthcare system builds awareness and enhanced decision-making for better patient treatment and support. These recommendations are just the beginning. All parts of the healthcare system and the general population will need to engage with this complex problem and work together to find solutions’.
The meeting decided to hold a large international conference in Iceland in 2020.
The meeting organiser, Dr Carina Håkansson (Psychotherapist, Sweden), commented:
‘All our hopes were exceeded. So many plans, local and international, emerged from this gathering of inspirational experts and activists. The time for change on this issue has clearly arrived’ carina@utvidgaderum.se
Participants commented:
‘Psychiatric drugs destroyed 10 years of my life. I am so happy that we are finally addressing this issue of how to get off these drugs, which effects literally millions of people.’ Olga Runciman, Denmark (Psychologist, IIPDW Board Member) +45 27851003, orunciman@gmail.com
‘Doctors should be able to prescribe the tapering medication strips I demonstrated at the meeting, which are required to stop safely. This is crucially important’. Dr Peter Groot, Netherlands (UMC University Hospital, Utrecht) +31 622290233 p.c.groot@ziggo.nl
‘As an NHS Psychiatrist, I am aware how many lives are ruined by over-medication. We need to recognise that there are alternatives which are more powerful and less harmful.’ Dr Rex Haigh, UK (Berkshire) +44 7768 546983 rex.haigh@gmail.com
‘The strong commitment all weekend, from researchers, clinicians and people with experience of psychiatric drugs was inspiring. The denying and minimizing of psychiatry and the drug companies will no longer prevail’. Professor John Read, UK (University of East London, IIPDW Board Member) +44 7944 853 783 john@uel.ac.uk
“I return to Brazil with a willingness to help the process of psychiatric reform in my country vigorously address the damage that the alliance between psychiatry and the pharmaceutical industry has done to our population.” Professor Fernando Freitas (FIOCRUZ, Member of IIPDW Faculty) + 55 21 2260 9200 ffreitas@ensp.fiocruz.br
© Mad in America 2019
Art and Transformation - Creating Justice in Mental Health Care
David Healy – Polluting Our Internal Environments: The Perils of Polypharmacy
Morgan Shields - Breaking Academia's Silence on Inpatient Psychiatry
Anders Sørensen - Tackling Psychiatric Drug Withdrawal Through Research and in Practice
Justin Karter - Exploring the Fault Lines in Mental Health Discourse
Jim Flannery - Sorry It's Not Funny – Comedy, Hip-Hop and Activism
Diana Rose - Is Service-User Research Possible in Mental Health?
Jon Jureidini – Evidence-Based Medicine in a Post-Truth World
Liam MacGabhann, Martha Griffin, Harry Gijbels and Elaine Browne - The Launch of Mad in Ireland
Beverley Thomson – Antidepressed - Antidepressant Harm and Dependence
John Read and Jeffrey Masson - Biological Psychiatry and the Mass Murder of “Schizophrenics”
Kaori Wada - How Grief Became a Disorder and What This Means About Us
Andrew Scull - Desperate Remedies: Psychiatry’s Turbulent Quest to Cure Mental Illness
Kristina Marusic - Pollution's Mental Toll
Jessica Taylor - Pathologized Since Eve - Women, Trauma, and Sexy but Psycho
Jock McLaren – The Biopsychosocial Model is a Mirage, Time for a Biocognitive Model?
Tara Thiagarajan - Mental Wellbeing Among Internet-enabled Populations of the World
Bruce Cohen - The Failings of “Mental Health”: How a Seemingly Benign Concept Might be Dangerous
Jennifer Barkin - New Tools to Support New Moms
Alice and Kenneth Thompson - Bringing Integrative Community Therapy to Pittsburgh
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast